Related Experiment Video

Updated: May 2, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
10:09

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence

Published on: January 7, 2019

7.7K

The N-myc Oncogene: Maximizing its Targets, Regulation, and Therapeutic Potential

Himisha Beltran1

  • 1Author's Affiliation: Weill Cornell Medical College, New York, New York hip9004@med.cornell.edu.

Molecular Cancer Research : MCR
|March 5, 2014
PubMed

Insights

This review details the role of N-myc (MYCN) in normal development and cancer, particularly neuroblastoma. It explores N-myc

Area of Science:

  • Molecular Biology
  • Oncology
  • Developmental Biology

Background:

  • N-myc (MYCN) is a transcription factor crucial for cellular processes.
  • It is recognized for its oncogenic activity, especially in neuroblastoma.
  • N-myc amplification and overexpression occur in neural and neuroendocrine tumors.

Purpose of the Study:

  • To review N-myc's role in normal development and cancer progression.
  • To highlight N-myc's transcriptional targets and regulatory mechanisms.
  • To discuss clinical implications, including biomarker potential and therapeutic targeting.

Main Methods:

  • Literature review of N-myc's function, regulation, and clinical relevance.
  • Analysis of transcriptional targets and regulatory pathways.
  • Discussion of therapeutic strategies targeting N-myc.

Main Results:

  • N-myc is a key regulator in normal development.
  • N-myc drives oncogenic progression in various tumors.
  • Specific transcriptional targets and regulatory mechanisms are identified.

Conclusions:

  • N-myc plays a dual role in development and oncogenesis.
  • Understanding N-myc's mechanisms offers therapeutic opportunities.
  • N-myc shows potential as a biomarker and therapeutic target in oncology.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

951
Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells09:37

Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells

Published on: August 25, 2021

1.5K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
4.8K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.0K